ITGR: Integer Holdings Corporation Stock

by  •  • Comments Off on ITGR: Integer Holdings Corporation Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 4,130.00
Enterprise Value ($M) 5,228.57
Book Value ($M) 1,525.01
Book Value / Share 45.52
Price / Book 2.71
NCAV ($M) -922.42
NCAV / Share -27.53
Price / NCAV -4.48

Profitability (mra)
Return on Invested Capital (ROIC) 0.04
Return on Assets (ROA) 0.03
Return on Equity (ROE) 0.07

Liquidity (mrq)
Quick Ratio 2.01
Current Ratio 3.32

Balance Sheet (mrq) ($M)
Current Assets 668.57
Assets 3,116.01
Liabilities 1,591.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,596.67
Operating Income 181.22
Net Income 90.65
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 180.21
Cash from Investing -163.37
Cash from Financing -18.01

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 11.41 -0.82
02-09 13G/A Dimensional Fund Advisors Lp 6.20 -2.63
01-30 13G/A Franklin Mutual Advisers Llc 2.80 -47.35
01-22 13G/A BlackRock Inc. 16.20 -3.64

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2024 ☐ TRANSITION REPORT P
2023-10-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2023 ☐ TRANSITION REPO
2023-07-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PU
2023-04-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT P

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 544,496 1,540,457 35.35
2024-04-24 305,994 1,026,085 29.82
2024-04-23 49,956 244,425 20.44
2024-04-22 48,342 267,412 18.08

(click for more detail)

Similar Companies
GMED – Globus Medical, Inc. HAE – Haemonetics Corporation
INSP – Inspire Medical Systems, Inc. MDT – Medtronic plc
MMM – 3M Company


Financial data and stock pages provided by
Fintel.io